Kestra Medical Technologies, Ltd.
- Last sale
- Nov 12, 2026 · -9.32%
- Market cap
- $1.71B
- 59.56M shares
- Filings
- 187
Q1 2026+59.0% FY26 yoy
Q1 2026N/M FY26 yoy
Q1 2026N/M FY26 yoy
Q1 2026derivedN/M FY26 yoy
Q1 2026N/M FY26 yoy
Q1 2026−58.0% FY25 yoy
- $1.71B
- —
- 16.0×
- 7.7×
- -7.19%
- —
Twelve months to Jul 31, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-04-30 | $95,126,000 | reported | |
| FY 2025 | 2025-04-30 | $59,815,000 | reported | |
| FY 2024 | 2024-04-30 | $27,814,000 | reported |
Surgical & medical instruments & apparatus
Kestra Medical Technologies, Ltd. is the 51st largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
OSUROrasure Technologies Inc$115.0M38.1%59.8%$285.1MANIKAnika Therapeutics, Inc.$112.8M5.9%9.6%$187.3MBBNXBeta Bionics, Inc.$100.3M53.9%73.0%$897.6MNPCENeuroPace Inc$100.0M25.1%21.5%$425.9M
KMTSKestra Medical Technologies, Ltd. (this company)$95.1M59.0%138.4%$1.7B
LUNGPulmonx Corp$90.5M8.0%59.7%$130.9MDCTHDelcath Systems, Inc.$85.2M129.1%3.2%$743.1MIRMDIradimed Corp$83.8M14.4%26.8%$1.1BTELATELA Bio, Inc.$80.3M15.8%48.4%$38.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Kestra Medical Technologies, Ltd. · CIK 1877184 · Engraved from SEC EDGAR